Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angipars for primary pulmonary hypertension
ACTRN12610000359033Phase 2Not yet recruiting
- Sponsor
- Pars Roos
- Start
- Jun 2010
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Angipars in pulmonary arterial hypertension (PAH), sponsored by Pars Roos. Primary endpoints: 6-minute walking distance and Pulmonary artery pressure by echocardiography. Planned start Jun 2010; status: not yet recruiting.
02
Drugs
Angipars
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on ACTRN12610000359033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000359033.